Medication Overuse Headache Clinical Trial
— MOHfollowupOfficial title:
Treatment of Medication-overuse Headache: 4 Years Follow up
Verified date | November 2020 |
Source | Norwegian University of Science and Technology |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
From 1 January 2004 to 31 December 2006 64 individuals with probable medication overuse headache were included in a randomized, 1-year open-labeled, multicentre study to evaluate the effect of early introduction of prophylactic treatment compared to abrupt withdrawal and with a control group (ClinicalTrials.gov number NCT00159588). In this follow-up, randomized patients still alive 4 years after primary inclusion time will be invited to a follow up interview, evaluating the headache complaints and the proportion of recurrent medication overuse.
Status | Completed |
Enrollment | 60 |
Est. completion date | May 2010 |
Est. primary completion date | May 2010 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 22 Years to 74 Years |
Eligibility | Inclusion Criteria: - Randomized during the initial trial during 2004-2006. |
Country | Name | City | State |
---|---|---|---|
Norway | Norwegian National headache Centre, NTNU | Trondheim |
Lead Sponsor | Collaborator |
---|---|
Norwegian University of Science and Technology |
Norway,
Hagen K, Albretsen C, Vilming ST, Salvesen R, Grønning M, Helde G, Gravdahl G, Zwart JA, Stovner LJ. A 4-year follow-up of patients with medication-overuse headache previously included in a randomized multicentre study. J Headache Pain. 2011 Jun;12(3):315 — View Citation
Hagen K, Albretsen C, Vilming ST, Salvesen R, Grønning M, Helde G, Gravdahl G, Zwart JA, Stovner LJ. Management of medication overuse headache: 1-year randomized multicentre open-label trial. Cephalalgia. 2009 Feb;29(2):221-32. doi: 10.1111/j.1468-2982.2008.01711.x. Epub 2008 Sep 24. — View Citation
Hagen K, Stovner LJ. A randomized controlled trial on medication-overuse headache: outcome after 1 and 4 years. Acta Neurol Scand Suppl. 2011;(191):38-43. doi: 10.1111/j.1600-0404.2011.01542.x. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Headache Days/Month After 4 Years Compared to Baseline | Change in headache days/month after 4 years compared to baseline | Baseline and after 4 years | |
Secondary | Change of Medication Days/Month Compared to Baseline | Baseline and after 4 years' of follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05720819 -
Biofeedback-VR for Treatment of Chronic Migraine
|
N/A | |
Terminated |
NCT02583425 -
Pilot Study of DFN-11 Injection in Medication Overuse Headache
|
Phase 2 | |
Recruiting |
NCT03655184 -
An Observation Study on Neuropsychology and Serum Melatonin Level in Patients With Medication Overuse Headache
|
||
Active, not recruiting |
NCT02993289 -
Is Detoxification Needed in Medication-overuse Headache?
|
N/A | |
Active, not recruiting |
NCT05608642 -
Intravenous Treatments Used in Medication Overuse Headache Bridge Treatment
|
N/A | |
Recruiting |
NCT03671681 -
Mindfulness Therapy for Chronic Migraine
|
N/A | |
Completed |
NCT01078012 -
Short Intervention for Medication Overuse Headache (MOH) - Pilot
|
N/A | |
Completed |
NCT03767062 -
Peripheral Nerve Block and Topiramate in the Treatment of Medication Overuse Headaches
|
N/A | |
Recruiting |
NCT01754571 -
CBT in Patients With Medication Overuse Headache
|
Phase 0 | |
Completed |
NCT02435056 -
Medication Overuse Headache (MOH) and an Innovative Approach
|
N/A | |
Recruiting |
NCT05452239 -
A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache
|
Phase 4 | |
Completed |
NCT01044251 -
Frovatriptan as a Transitional Therapy in Medication Overuse Headache
|
Phase 2 | |
Completed |
NCT04336267 -
Anodal tDCS in Chronic Migraine With Medication Overuse
|
N/A | |
Enrolling by invitation |
NCT01752439 -
Effects of Transcranial Direct Current Stimulation in Refractory Chronic Migraine and Medication-overuse Headache
|
N/A | |
Completed |
NCT00833209 -
Orbitofrontal Cortex (OFC) Influence on Addictive Medication Overuse Headache (MOH) Deriving From Migraine
|
N/A | |
Completed |
NCT04772742 -
Eptinezumab in Adults With Migraine and Medication Overuse Headache
|
Phase 3 | |
Completed |
NCT04228809 -
tDCS in Chronic Migraine With Medication Overuse (Edisom)
|
N/A | |
Not yet recruiting |
NCT05334927 -
China HeadAche DIsorders RegiStry
|
||
Completed |
NCT04090333 -
Endocrinological Profile in Patients With Medication-overuse Headache Before and After Withdrawal Therapy
|
||
Recruiting |
NCT01317992 -
Ibudilast in the Treatment of Medication Overuse Headache
|
Phase 1/Phase 2 |